Breast cancer, the most common cancer in women worldwide, is a heterogeneous disease composed of a broad spectrum of tumor subtypes with different biological characteristics and clinical behavior. The primary breast cancer markers traditionally used in routine clinical practice to establish the disease's diagnosis, prognosis, and therapy are estrogen receptor (ER), progesterone receptor (PR), and human [...]